Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 2

Sponsor Class

INDUSTRY 6OTHER 5NETWORK 2NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 6Breast 5Thoracic 4Sarcoma 3Gynecologic 2Genitourinary 1Dermatologic 1CNS 1

Conditions

Uterine Cervical Neoplasms 2

Interventions

Cisplatin 63Paclitaxel 56Carboplatin 38Taxes 24Radiotherapy 21Gemcitabine 16Brachytherapy 15Filgrastim 14Doxorubicin 13Topotecan 12Platinum 121,2-diaminocyclohexaneplatinum II citrate 12Docetaxel 11Radiation 7Granulocyte Colony-Stimulating Factor 7Chemotherapy, Adjuvant 7pegfilgrastim 6Surgical Procedures, Operative 6Radiotherapy, Intensity-Modulated 6Polymerase Chain Reaction 6Ifosfamide 6Etoposide 6Watchful Waiting 5Radiotherapy, Conformal 5Pemetrexed 5Gene Expression Profiling 5Fluorouracil 5Celecoxib 5Amifostine 5Observation 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Vinorelbine × Gynecologic × Clear all
NCT00064077 2018-10-17

Comparison of Four Combination Chemotherapy Regimens Using Cisplatin in Treating Patients With Stage IVB, Recurrent, or Persistent Cancer of the Cervix

GOG Foundation

Phase 3 Completed
513 enrolled 15 charts
Gynecologic

Uterine Cervical Neoplasms

NCT00002813 2013-05-27

Combination Chemotherapy in Treating Patients With Recurrent or Refractory Cervical Cancer

GOG Foundation

Phase 2 Completed
62 enrolled
Gynecologic

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡